Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Stock Price Prediction
Update at 5:00pm EST
2.203 - 2.211
2.211 - 2.217
2.029 - 2.039
2.039 - 2.047
2.125 - 2.14
2.14 - 2.153
as of: 2019-10-14 4:45:25 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.CANF has closed below upper band by 40.5%. Bollinger Bands are 60.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CANF's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.